Insulin glargine
Basaglar, Lantus, Semglee, Toujeo, Optisulin (insulin glargine) is a protein pharmaceutical. Insulin glargine was first approved as Basaglar on 2000-04-20. It is used to treat hyperglycemia, type 1 diabetes mellitus, and type 2 diabetes mellitus in the USA. It has been approved in Europe to treat diabetes mellitus.
| Trade Name | Lantus, Optisulin, Toujeo |
|---|---|
| Common Name | Insulin glargine |
| Indication | diabetes mellitus, hyperglycemia, type 1 diabetes mellitus, type 2 diabetes mellitus |
| Drug Class |
